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Letters to the Editor
Hibernating Myocardium, Apoptosis,
and a Simple Mathematical Task
We read with extreme interest the recent report by Elsasser et al.
(1). Their study reliably shows that both apoptotic and autophagic
cell death occur in hibernating myocardium and may be responsi-
ble for progressive clinical deterioration and lack of functional
recovery.
However, we are afraid the investigators may have made an
inaccurate estimate of apoptotic cell death rate. The researchers
indeed report an incidence of apoptosis of 0.002% (i.e., 1 of 50,000
cells). These data would suggest that at least 50,000 cells were
counted per patient in order to ascertain whether at least one was
apoptotic. But the investigators fail to clarify this issue thoroughly.
This point is particularly relevant when considering the electron
microscopy data. Considering the specific limitations of electron
microscopy we would imagine that the investigators evaluated not
more than 100 cells at electron microscopy per case. Yet assuming
100 cells examined per case and an apoptotic rate of 1 in 50,000,
the chance of randomly finding an apoptotic cell at the electron
microscope level in a single case would be 1 in 500. Accordingly,
the probabilty of 3 positive cases at electron microscopy would be
only 1 in 125 million.
In conclusion, we find the message given by Elsasser et al. (1)
extremely attractive and clinically relevant. However, we believe
that they might have underestimated the incidence of apoptotic
myocytes at confocal microscopy. We would greatly appreciate it if
the investigators could clarify these apparent inconsistencies.
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We thank Dr. Abbate and colleagues for their interest in our work
(1). The major point of our recent publication is the fact that
autophagic cell death as described previously in patients with dilated
cardiomyopathy (2) is an important mechanism for killing myocytes
in hibernating myocardium and that apoptosis seems to be of less
importance. We are fully aware of the many technical problems that
might occur when attempting a quantitative analysis of the rate of cell
death, be it apoptosis, autophagic cell death, or necrosis (3). In our
experience, electron microscopy is not a suitable method for deter-
mining the rate of cell death, which has been emphasized by others as
well (4). Therefore, we use the confocal microscope. We analyze
entire sections, and as many cells as are available from the patient’s
material; we count the total number of nucleated myocytes per patient
and we determine the number of specifically labeled cells. This
information is then statistically analyzed on the basis of individual data
from each patient and ultimately expressed as a percentage. In a final
stage, results are summarized for an entire group of patients, and
different groups are compared by employing appropriate statistical
tests. Using this procedure each patient is weighted equally, even if
there are no labeled cells present.
We read with interest Dr. Abbate and colleagues’ work on
myocardial apoptosis in patients with unfavorable left ventricular
remodeling and we noticed the unusually high rates of apoptosis
reported for both infarcted myocardium and areas remote from the
infarct (5). Unfortunately, a precise indication of the total number
of myocytes examined is lacking from the description of methods,
rendering difficult an interpretation of these results. It would have
been more convincing had Dr. Abbate and colleagues used the
same criteria in his own work that he requests from ours.
There is no doubt, however, that myocyte death is a major
contributing factor to the deterioration of cardiac function in
pathological situations in the human heart, either in postinfarction
remodeling or in hibernating myocardium.
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The Year in Congenital Heart Disease
The review by Graham (1) is an excellent and welcome summary
of surgical, interventional, and medical progress in congenital heart
disease. There are sufficient data to allow the reader to form an
opinion, backed up by specific references, as well as useful critical
remarks of consensus.
I was particularly interested in his comments about postopera-
tive pulmonic insufficiency in patients with tetralogy who are now
being recognized as a significant problem in a growing population
of postoperative adults. Initially, we all had hoped that pulmonic
insufficiency would not be a problem, and surgeons were urged to
abolish completely any gradient across the right ventricular (RV)
outflow tract because of concerns that if the RV pressure was still
elevated it would create a risk for arrhythmias, and even sudden
death. As these youngsters lived with their insufficiency, they
developed large right ventricles, but were generally asymptomatic.
This tolerance of volume overload is also characteristic of the left
ventricle, but in their teens and twenties those young patients are
beginning to need valve replacements. Unfortunately, we do not
have the same reliable guidelines (ejection fraction) for the right
ventricle as we have for the left.
Although we will have to face difficult decisions for our current
generation of postoperative tetralogy patients with severe pulmonic
insufficiency—considering the limited half-life for biological valve
replacements, as Graham (1) mentioned—shouldn’t we revisit the
degree of insufficiency being created in today’s infants and chil-
dren? Many years ago one of the pioneers of surgical correction of
tetralogies anticipated the problem: Frank Gerbode (personal
communication, June 1965) warned that it would be better
physiologically to leave a moderate degree of pulmonic stenosis
rather than create severe pulmonic insufficiency. He reasoned that
the less compliant right ventricle associated with moderate stenosis
would resist the insufficiency, and that moderate stenosis would be
better tolerated.
As a minimum, we should review the evidence as to whether we
have unnecessarily accepted all the problems of severe pulmonic
replacement absent a test of the alternate approach of moderation
in disabling the valve at surgery.
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It is a pleasure to respond to Dr. Guntheroth’s comments regard-
ing my paper (1) and the current state of affairs for patients with
tetralogy of Fallot and significant postoperative pulmonary insuf-
ficiency. As he clearly states, many of these adult patients have an
enlarged right ventricle that can show a progressive decrease in
ventricular function, which at some point becomes partially or
completely irreversible. In addition, patients with a marked degree
of right ventricular (RV) enlargement and decreased function
appear to be potentially more susceptible to significant arrhyth-
mias, which, on rare occasions, can be life-threatening. The
optimal treatment for these patients is theoretically available with
pulmonary valve replacement, which can be performed with low
mortality and morbidity. When this procedure is done early
enough in the course of the inexorable decrease of RV function,
there is a decrease in RV size (usually modest) and improvement in
RV function and exercise ability. Unfortunately, valves that have
been used in the pulmonary position have, under most circum-
stances, shown a half-life of only 10 to 12 years. The newer, larger
bio-prosthetic pericardial valves have shown some promise for
holding on longer, but the data are not complete on these valves to
make that a clear-cut alternative with promise for a longer interval
between reoperations.
The search for an optimal bio-prosthetic valve (one that can be
grown from one’s blood cells outside the body and then re-
implanted and possibly delivered with a catheter-interventional
technique) is the hope of the future.
In the interim, I agree with Dr. Guntheroth that we should
continue to revisit the issue of leaving mild pulmonary stenosis
rather than create severe pulmonary insufficiency. This can be a
difficult management decision in the operating room as the more
severe tetralogy patients with severe outflow obstruction and small
main pulmonary arteries are not amenable to successful repair
without leaving them with significant pulmonary insufficiency.
Moreover, when one has to do a significant ventriculotomy and
leave moderate stenosis, right ventricle dysfunction can occur early
in the postoperative period and be even more severe than that
associated with moderate/severe pulmonary insufficiency.
During follow-up visits, postoperative tetralogy patients, most
of whom have had an excellent overall outcome long term,
continue to need attention to their RV size and function and to the
potential for rhythm disorder; this should be done by physicians
with expertise in both adult cardiology and congenital heart
disease. Magnetic resonance imaging of the right ventricle with
quantification of RV volumes and ejection fraction as well as
exercise testing with maximum VO2 measurement can be quite
useful in terms of serial assessment and consideration for interven-
tion. There is a growing need for training the next generation of
physicians who can provide optimal care for this burgeoning group
of adults with congenital heart disease.
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